CD21/CD35 Antibody, anti-mouse, APC, REAfinity™ 130-111-653 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD21/CD35 Antibody, anti-mouse, APC, REAfinity™

Miltenyi Biotec's CD21/CD35 Antibody, anti-mouse, APC, REAfinity™ is a Human monoclonal antibody. The CD21/CD35 Antibody, anti-mouse, APC, REAfinity™ was generated using Cr2 as the antigen. It reacts with Mouse. This antibody has been shown to work in applications such as: Staining, Fluorescence, Microscopy, Flow Cytometry, Immunofluorescence, and Immunohistochemistry.

Product Specs
ItemCD21/CD35 Antibody, anti-mouse, APC, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-111-653
Quantity150 µg in 1 mL
ApplicationsFlow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
Conjugate/TagAPC
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
IsotypeIgG1
CloneREA800
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
NCBI Full Gene Namecomplement receptor 2
NCBI Gene AliasesC3D, C3DR, CD21, CD35, Cr, Cr-, Cr-1, Cr-2, Cr1
Clonalitymonoclonal
Reactivitymouse
Concentration1:50
ModificationsRecombinantly engineered
TargetCD21/CD35
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Complement receptors CD21 and CD35 in humoral immunityImmunological reviewsOctober 1, 2007Roozendaal R, Carroll MC.

(2) Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cellsJournal of virologyJuly 1, 2006Brockman MA, Verschoor A, Zhu J, Carroll MC, Knipe DM.

(3) Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cellsJournal of immunology (Baltimore, Md. : 1950)February 15, 1998Kozono Y, Abe R, Kozono H, Kelly RG, Azuma T, Holers VM.

Be the First to Write a Review!